Scott BOIKO,Justin CIDADO,Lisa DREW,Teresa PROIA,Maryann SAN MARTIN
申请号：
US16650042
公开号：
US20200289506A1
申请日:
2018.09.24
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to combination of a BTK inhibitor and an inhibitor of CDK9 for use in the treatment of cancer in a subject. The BTK inhibitor can be acalabrutinib, ibrutinib, or ONO/GS-4059； and the inhibitor of CDK9 can be AZD4573, BAY-1251152, BAY-1143572, CYC065, alvocidib, AT7519, voruciclib, roniciclib, or dinaciclib.
